The North America Aciclovir Market is expected to maintain a strong position through 2034, supported by the region's established healthcare infrastructure, high diagnosis rates for herpes simplex virus (HSV) infections, broad access to prescription medicines, and continued demand for antiviral therapies. Aciclovir remains an important treatment option for herpesvirus-related conditions,...